VeriVasc, Inc.

VeriVasc is a Madison-based UW-Madison spinout developing AortIQ, software that turns routine chest CT scans into quantitative measurements of the thoracic aorta. Aortic disease is still managed with a single manual diameter measurement that misses many at-risk patients. AortIQ compares each patient's entire aorta to a personalized normal, adjusted for body size and age, helping clinicians identify high-risk patients earlier. AortIQ is in development and not yet FDA-cleared.